Literature DB >> 9696832

Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor.

W B Klimstra1, K D Ryman, R E Johnston.   

Abstract

Attachment of Sindbis virus to the cell surface glycosaminoglycan heparan sulfate (HS) and the selection of this phenotype by cell culture adaptation were investigated. Virus (TR339) was derived from a cDNA clone representing the consensus sequence of strain AR339 (K. L. McKnight, D. A. Simpson, S. C. Lin, T. A. Knott, J. M. Polo, D. F. Pence, D. B. Johannsen, H. W. Heidner, N. L. Davis, and R. E. Johnston, J. Virol. 70:1981-1989, 1996) and from mutant clones containing either one or two dominant cell culture adaptations in the E2 structural glycoprotein (Arg instead of Ser at E2 position 1 [designated TRSB]) or this mutation plus Arg for Ser at E2 114 [designated TRSB-R114]). The consensus virus, TR339, bound to baby hamster kidney (BHK) cells very poorly. The mutation in TRSB increased binding 10- to 50-fold, and the additional mutation in TRSB-R114 increased binding 3- to 5-fold over TRSB. The magnitude of binding was positively correlated with the degree of cell culture adaptation and with attenuation of these viruses in neonatal mice. HS was identified as the attachment receptor for the mutant viruses by the following experimental results. (i) Low concentrations of soluble heparin inhibited plaque formation on and binding of mutant viruses to BHK cells by >95%. In contrast, TR339 showed minimal inhibition at high concentrations. (ii) Binding and infectivity of TRSB-R114 was sensitive to digestion of cell surface HS with heparinase III, and TRSB was sensitive to both heparinase I and heparinase III. TR339 infectivity was only slightly affected by either digestion. (iii) Radiolabeled TRSB and TRSB-R114 attached efficiently to heparin-agarose beads in binding assays, while TR339 showed virtually no binding. (iv) Binding and infectivity of TRSB and TRSB-R114, but not TR339, were greatly reduced on Chinese hamster ovary cells deficient in HS specifically or all glycosaminoglycans. (v) High-multiplicity-of-infection passage of TR339 on BHK cell cultures resulted in rapid coselection of high-affinity binding to BHK cells and attachment to heparin-agarose beads. Sequencing of the passaged virus population revealed a mutation from Glu to Lys at E2 70, a mutation common to many laboratory strains of Sindbis virus. These results suggest that TR339, the most virulent virus tested, attaches to cells through a low-affinity, primarily HS-independent mechanism. Adaptive mutations, selected during cell culture growth of Sindbis virus, enhance binding and infectivity by allowing the virus to attach by an alternative mechanism that is dependent on the presence of cell surface HS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696832      PMCID: PMC109960     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  Mechanism of altered Sindbis virus neurovirulence associated with a single-amino-acid change in the E2 Glycoprotein.

Authors:  P C Tucker; D E Griffin
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

2.  Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types.

Authors:  T J Wickham; P W Roelvink; D E Brough; I Kovesdi
Journal:  Nat Biotechnol       Date:  1996-11       Impact factor: 54.908

3.  Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.

Authors:  R I Montgomery; M S Warner; B J Lum; P G Spear
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

4.  Amino acid changes in the Sindbis virus E2 glycoprotein that increase neurovirulence improve entry into neuroblastoma cells.

Authors:  P C Tucker; S H Lee; N Bui; D Martinie; D E Griffin
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  Deduced consensus sequence of Sindbis virus strain AR339: mutations contained in laboratory strains which affect cell culture and in vivo phenotypes.

Authors:  K L McKnight; D A Simpson; S C Lin; T A Knott; J M Polo; D F Pence; D B Johannsen; H W Heidner; N L Davis; R E Johnston
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus.

Authors:  T C Mettenleiter; L Zsak; F Zuckermann; N Sugg; H Kern; T Ben-Porat
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

7.  Specificity in the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparin.

Authors:  J D San Antonio; J Slover; J Lawler; M J Karnovsky; A D Lander
Journal:  Biochemistry       Date:  1993-05-11       Impact factor: 3.162

8.  Specificity studies on the heparin lyases from Flavobacterium heparinum.

Authors:  U R Desai; H M Wang; R J Linhardt
Journal:  Biochemistry       Date:  1993-08-17       Impact factor: 3.162

9.  Effect of ionic strength on the binding of Sindbis virus to chick cells.

Authors:  J S Pierce; E G Strauss; J H Strauss
Journal:  J Virol       Date:  1974-05       Impact factor: 5.103

10.  Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan.

Authors:  J A Marcum; D H Atha; L M Fritze; P Nawroth; D Stern; R D Rosenberg
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157

View more
  204 in total

1.  Identification of functional domains in the 14-kilodalton envelope protein (A27L) of vaccinia virus.

Authors:  M I Vázquez; M Esteban
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes.

Authors:  J M Smit; R Bittman; J Wilschut
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

3.  Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation.

Authors:  A P Byrnes; D E Griffin
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  An amino acid substitution in the coding region of the E2 glycoprotein adapts Ross River virus to utilize heparan sulfate as an attachment moiety.

Authors:  M L Heil; A Albee; J H Strauss; R J Kuhn
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  PE2 cleavage mutants of Sindbis virus: correlation between viral infectivity and pH-dependent membrane fusion activation of the spike heterodimer.

Authors:  J M Smit; W B Klimstra; K D Ryman; R Bittman; R E Johnston; J Wilschut
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  Potential sources of the 1995 Venezuelan equine encephalitis subtype IC epidemic.

Authors:  A C Brault; A M Powers; G Medina; E Wang; W Kang; R A Salas; J De Siger; S C Weaver
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Infection of human cells by dengue virus is modulated by different cell types and viral strains.

Authors:  M S Diamond; D Edgil; T G Roberts; B Lu; E Harris
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo.

Authors:  C W Mandl; H Kroschewski; S L Allison; R Kofler; H Holzmann; T Meixner; F X Heinz
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

9.  Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein.

Authors:  J P Gardner; I Frolov; S Perri; Y Ji; M L MacKichan; J zur Megede; M Chen; B A Belli; D A Driver; S Sherrill; C E Greer; G R Otten; S W Barnett; M A Liu; T W Dubensky; J M Polo
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

10.  Adaptation of alphaviruses to heparan sulfate: interaction of Sindbis and Semliki forest viruses with liposomes containing lipid-conjugated heparin.

Authors:  Jolanda M Smit; Barry-Lee Waarts; Koji Kimata; William B Klimstra; Robert Bittman; Jan Wilschut
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.